Researchers at ETH Zurich combined two CRISPR-Cas methods to decipher how mutations in a cell’s genome affect its function.

University of Wisconsin–Madison researchers targeting a group of hereditary neurodegenerative diseases have found success ...

In recent years, scientists have created a range of new methods based on CRISPR-Cas technology for precisely editing the ...

Crispr Therapeutics AG (CRSP) Company Description: CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform ...

The patents have been officially revoked following the pair's voluntary decision to withdraw them | Withdrawal follows ...

Genes contain instructions for making proteins, and a central dogma of biology is that this information flows from DNA to RNA to proteins. But only two percent of the human genome actually encodes ...

Crispr has already secured a historic first approval for a CRISPR/Cas9 drug and has several more potential blockbuster ...

CRISPR/Cas9 is a revolutionary gene-editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad ...

CVC’s opponents argued, and the Appeal Board appears to have agreed, that without knowledge of the PAM sequence and its ...

Genes contain instructions for protein production, with the central dogma of biology stating that this information flows from ...